Skip to content
GREEN FUTURETECH.
Explore

Research libraryThe Compliance Frontier

Chapter 12 of 14 · Part IV · Draft web edition

Contracts should fund evidence and remedy rather than transfer slogans

A workable supplier agreement defines the information, responsibility, resources and decisions on each side.

Sections
7
Exhibits
5
Minutes
27
Sources
13
EX 51 · Test work and agreed payer: Supplier to buyer control 5, Evidence to remedy 5

The cloth is woven from this chapter's 5 exhibits: each weft is one exhibit's own data, normalised; each warp group is a section. The probe reads the exhibit's own value where it crosses. Procedural visualisation, not a measurement.

The chapter as a draft: 7 sections, 3 exhibit wefts, one shuttle.

Lead exhibit · 51Decision mapillustrativeA duty, a task and a cost owner are different allocations
Supplier to buyer control →Evidence to remedy →Buyer corporate due d…Supplier batch captureTest work and agreed…Corporate reporting o…Protection and remedy…

Read-outBuyer corporate due diligence: Supplier to buyer control 9, Evidence to remedy 8

Method and source

Illustrative GFT contract-design map grounded in the cited corporate-duty and worker-protection frameworks. X runs from supplier operational control (0) to buyer decision control (10). Y runs from routine evidence administration (0) to prevention, protection and remedy (10). Positions are not legal scores, liability findings or measured responsibilities. Cost ownership must be separately stated in the evidence schedule.

Unit: illustrative allocation coordinates from 0 to 10. Status: illustrative. Sources: S02, S25, S35. Illustrative figures are teaching examples, not measured factory results.

The chapter's warpBar: share of the reading · square: an exhibit

Section 12.0 · Opening · 1 min · no exhibit of its own · one movement Go to section ↓

Overture · 1 min

A supplier agreement should turn sustainability language into funded, inspectable work. It should name the legal duty holder, the party performing each task, the evidence to be produced, the payer, the decision owner and the route to remedy. A broad warranty cannot do that work. It can make the supplier responsible for words while leaving tests, worker engagement, record retrieval and corrective action without time or money. GFT recommends a bounded evidence schedule attached to the commercial terms, with unresolved legal questions kept visible rather than hidden inside a promise of universal compliance.

¶ 01

Four allocations need to remain distinct. A statute may place responsibility on a buyer, importer, manufacturer or another economic operator. A contract can assign an operational task to a different party, but that assignment does not by itself move the statutory duty. The payer of an invoice is a third question. Authority to release a product, suspend work or approve a remedy is a fourth. Collapsing these questions into “supplier shall comply” prevents both parties from seeing who must act when evidence is missing or harm is found.[S02][S33][S35]

¶ 02 · 3 sources

S02S33S35

This chapter is an operating-design analysis as of 30 October 2026, not legal, tax or investment advice. Its clause topics and schedules are proposals for transaction-specific review, not language ready for signature. The parties need to verify the current operative acts, national implementation, product classification, governing law and their actual sales route. No executed GFT supply contract, buyer acceptance, legal opinion or implemented remedy system is claimed.[S02][S35]

¶ 03 · 2 sources

S02S35

12.13 min · 9 paragraphs · 1 exhibit

A supplier clause cannot erase a buyer corporate duty

Related · chapter 149 paragraphs step it

Related exhibit 60 · chapter 14Decision mapillustrativeCritical failures remain visible at the release gate
Administration to process change →Limited to decisive consequence →Duplicate buyer schemaMissing reporting fie…Composition label mis…Unreviewed specificat…Unresolved chemical e…Worker protection or…

Read-outDuplicate buyer schema: Administration to process change 2, Limited to decisive consequence 1

Method and source

Illustrative GFT decision map. X runs from routine evidence administration (0) to operational process change (10). Y runs from limited release consequence (0) to decisive protection or release consequence (10). Positions are categorical design aids, not measured risk, legal findings or supplier scores. Sources support the issue categories, not the coordinates.

Unit: illustrative decision coordinates from 0 to 10. Status: illustrative. Sources: S09, S16, S17, S33. Illustrative figures are teaching examples, not measured factory results.

Read this exhibit in its chapter ↗
12.1 · Introduction · paragraph 1 of 9

The amended Corporate Sustainability Due Diligence Directive establishes a corporate process for companies within its scope. The Commission describes the identification and addressing of actual and potential adverse human-rights and environmental impacts across a company's own operations, its subsidiaries and its chain of activities. A supplier can provide records, access and corrective action that support that process. It cannot become the buyer's corporate judgement merely by signing a questionnaire or warranty.[S02]

The adopted amending text makes the limitation explicit. Participation in industry or multi-stakeholder initiatives, independent third-party verification and contractual clauses can support implementation, yet a company may nevertheless be held liable in accordance with national law. The contractual question is therefore not how to make buyer responsibility disappear. It is how to obtain useful performance and evidence while preserving the responsibilities that each party holds in law.[S35]

A generic warranty also confuses different propositions. A supplier may accurately state that a named report covers a named batch and test method. That is a representation about identified evidence. A promise that every future product, site and upstream activity will always comply with every present and future rule is a much broader obligation. It conceals the product boundary, the period, the evidence available and the party able to control the relevant process. The first proposition can be checked. The second needs extensive qualification and legal review before anyone relies on it.

GFT proposes a clause review that begins with scope. Identify the contracting entities, products, production sites, sales route, order period and relevant economic-operator roles. Then identify each requested output: a declaration, record extract, laboratory test, site visit, corrective plan, worker interview, claim approval or incident notice. The review should state what each output establishes, what it excludes and which decision it informs. This prevents a document request from becoming an accidental transfer of undefined legal exposure.

Access provisions need the same precision. “Buyer may audit at any time” does not explain the triggering purpose, notice, scope, competence, confidentiality, worker safety or treatment of personal information. A workable provision defines the proposed access route and the records or personnel genuinely needed. It also provides for urgent concerns without making every routine review an emergency. Where GDPR applies, purpose limitation and data minimisation remain separate tests; contractual consent between companies does not itself establish lawful processing of worker data.[S23]

Change notification should follow controllable events. Relevant examples include a changed material specification, a new subcontractor, a different production site, a revised buyer template or evidence that an earlier statement was wrong. The clause should say who notifies whom, what information accompanies the notice and which decisions pause pending review. It should not require disclosure of every minor operational event irrespective of its effect on the product or people.

Exhibit 51 separates these allocations as an illustrative planning map. Horizontal position represents proposed operational or decision control, not legal liability. Vertical position represents the move from routine evidence administration towards prevention, protection and remedy. The labels deliberately distinguish the buyer's corporate process from the supplier's record work and from the shared decision to fund a test.

The map is not an organisational chart. A supplier can control the underlying records while the buyer controls its corporate assessment. A laboratory can perform a test while another party pays and a qualified economic operator retains its product duties. A worker-protection decision may require buyer action on purchasing terms as well as supplier action on site. The schedule should record those interfaces instead of assigning one name to every box.[S33]

Escalation belongs in the clause architecture from the start. A missing document may need clarification. A failed test may need product containment and technical review. A credible concern about coercion may need immediate protection even before the evidence is complete. These routes require different authority and should not be reduced to one commercial default notice. The later escalation ladder in this chapter therefore separates evidence resolution, product decisions and worker remedy.

12.22 min · 8 paragraphs · read with a related exhibit

The reporting cap needs purpose-specific contract treatment

The reporting cap belongs to a defined value-chain relationship and reporting purpose. The adopted Accounting Directive amendment uses an average of 1,000 employees during the preceding financial year, assessed on the balance sheet date, within its protected-undertaking definition. The fuller status and self-declaration tests belong to the reporting analysis. For contract drafting, the essential point is to record the applicable status and voluntary-standard boundary instead of labelling every smaller supplier “protected”.[S35]

For reporting required by that Directive, a protected undertaking may decline information exceeding the voluntary standards. The reporting undertaking must not require that excess through contractual or other arrangements for its reporting requirements. Where an excess request is made, it must identify the excess and the statutory right to decline. The schedule should therefore tag reporting fields and their standard boundary rather than burying them in a general annex.[S35]

¶ 02 · 1 source

S35

Contrary wording has a precise consequence: the offending provision is not binding, while the remaining contract provisions retain their binding nature. The whole agreement is not void. A side letter should not be used to compel the same excess for the same purpose. The review should isolate that requirement and preserve the valid commercial work around it.[S35]

¶ 03 · 1 source

S35

The cap is not a general refusal mechanism. The adopted text preserves information requests for other purposes, including compliance with Union due-diligence requirements. Product-safety duties also remain operational: EU guidance states that products sold in the EU must be safe regardless of where they were made, and businesses must act when they identify unsafe products. A supplier should not invoke a reporting cap to withhold necessary safety evidence or delay corrective action.[S33][S35]

¶ 04 · 2 sources

S33S35

CSDDD safeguards answer a different question. They use necessity and, for smaller partners, reasonable alternative-source tests for an in-depth assessment. The schedule must classify the request before choosing a protection, not transfer a reporting threshold to due-diligence or product work.[S35]

¶ 05 · 1 source

S35

This distinction has a practical drafting consequence. A single clause saying “supplier shall provide all sustainability information requested” merges reporting, risk assessment, product release, legal investigation, marketing and commercial specification. GFT recommends replacing that formula with field groups that state their purpose and evidence route. Where the supplier voluntarily offers information beyond a reporting ceiling, the submission should say so and preserve any confidentiality and use restrictions. Voluntary sharing should not silently become an unlimited precedent for every later request.

¶ 06

Legal status remains a dated dependency. The Commission's acts register opened for this research lists the July 2026 voluntary value-chain standards as adopted but not in force until Official Journal publication. The final contract review must check the effective standard version and applicable national implementation on the relevant date. It should not treat the 2025 VSME recommendation and the later voluntary standards as interchangeable instruments.[S03][S04][S05]

¶ 07 · 3 sources

S03S04S05

Note

12.33 min · 7 paragraphs · read with a related exhibit

Purchasing practices affect what the supplier can deliver

The OECD describes garment and footwear supply chains as fragmented and multi-tiered, extending from raw-material production to finished goods and from informal homeworkers to large retailers. That structure justifies attention to the relationships around an order. It does not establish that a particular buyer's price, forecast or lead time caused harm at a particular supplier. The opened source excerpt used here supports the sector structure; the purchasing mechanisms below are GFT proposals to investigate and negotiate, not reported findings about the fictional case.[S07]

A contract can make those mechanisms visible before a deadline fails. The order brief should identify the product specification, approved capacity, production route, evidence deliverables and decision dates. Forecasts should be labelled as forecasts rather than treated as guaranteed volumes. Capacity commitments should distinguish available production time from time required for testing, worker consultation, record review and corrective action. None of these schedules proves that a safe or compliant order will result. They make the operating assumptions available for challenge.

¶ 02

Specification changes need a controlled route. A new dye recipe can invalidate the relevance of earlier chemical evidence. A new trim supplier can change the product file. A buyer-requested label or packaging change can alter the claims and information review. The change order should therefore ask more than whether the line can physically make the revision. It should identify affected evidence, additional work, responsible reviewer, payer, revised timing and any hold on release.

¶ 03

Subcontracting requires an equivalent control. The supplier should disclose the proposed activity and site at the level needed for the actual risk and product assessment. Approval should not become a pretence that the buyer directs every employment decision, nor should confidentiality become a reason to hide production from the evidence system. The parties should agree which changes require prior review and how urgent capacity problems are escalated before unapproved work enters the order.

¶ 04

Price and timing discussions should include feasibility rather than relying on a later default clause. If the requested delivery date leaves insufficient time for an agreed test or protective investigation, the supplier should record the constraint and propose a decision: revise the date, narrow the product change, add suitable resources or decline the commitment. Accepting the date while planning to bypass the evidence gate is not a commercial solution. Nor does a buyer's willingness to pay an administrative fee settle whether the underlying action is lawful or effective.

¶ 05

Shared planning can still leave responsibility unclear. A buyer may provide forecasts and technical support, while the supplier controls daily staffing and production. The contract should avoid both extremes: buyer instructions that ignore operational knowledge, and supplier acceptance of requirements it knows it cannot meet. GFT recommends an exceptions review in which operations, quality, people and commercial roles can surface conflicts before the order is confirmed. Detailed line balancing and inventory mechanics belong to the companion operations papers; the contractual task is to make the conflict actionable.

¶ 06

The purchasing review should also examine what happens when evidence reveals a problem. If every delay automatically triggers cancellation, the parties may create an incentive to conceal uncertainty. If every problem automatically extends the order, a critical product or worker issue may be ignored. A better schedule distinguishes remediable administrative gaps from conditions requiring containment, urgent protection or refusal to ship. It records who may choose each route and how the worker and product consequences are assessed.

¶ 07

12.44 min · 8 paragraphs · 1 exhibit

Testing and evidence work require explicit resources

Step 1 of 7Opening

Exhibit 52 · illustrativeAn added evidence request should be priced by its actual work

01002003004000Opening+60Technicalreview+140Laboratory+32Translation+50Workerengagement+30Portaladaptation312Total0200400Opening0Technical review+60Laboratory+140Translation+32Worker engagement+50Portal adaptation+30Total312

Opening

Opening: total 0. Running total 0 illustrative cost units · illustrative

The Commission states that companies within the amended CSDDD scope bear the costs of establishing and operating their due-diligence process, together with costs linked to appropriate measures to prevent, mitigate…

Technical review

Technical review: adds 60. Running total 60 illustrative cost units · illustrative

Laboratory

Laboratory: adds 140. Running total 200 illustrative cost units · illustrative

Translation

Translation: adds 32. Running total 232 illustrative cost units · illustrative

Worker engagement

Worker engagement: adds 50. Running total 282 illustrative cost units · illustrative

Portal adaptation

Portal adaptation: adds 30. Running total 312 illustrative cost units · illustrative

Total

Total: total 312. Running total 312 illustrative cost units · illustrative

The method behind it: Worked example: evidence added after the garment price.

Method and source · Exhibit 52

Illustrative arithmetic only: technical review = 6 hours x 10 cost units = 60; laboratory allowance = 140; translation = 4 hours x 8 = 32; worker-engagement preparation = 5 hours x 10 = 50; portal adaptation = 3 hours x 10 = 30. Total = 60 + 140 + 32 + 50 + 30 = 312. All rates and quantities are invented for the worked model, not market fees or a GFT cost baseline.

Unit: illustrative cost units. Status: illustrative. Illustrative figures are teaching examples, not measured factory results.

12.4 · the bodyExhibit 52 above; its figures are illustrative where marked.

The Commission states that companies within the amended CSDDD scope bear the costs of establishing and operating their due-diligence process, together with costs linked to appropriate measures to prevent, mitigate, bring to an end or minimise adverse impacts where needed. That statement identifies corporate cost responsibility. It does not decide which party must pay every supplier invoice, nor does it supply a tariff for laboratory work, translation, systems or audits. Those allocations belong in the negotiated schedule.[S02]

GFT proposes separating three kinds of expenditure. The first is reusable setup, such as a controlled evidence index, product-role assessment or data dictionary. The second is order-specific recurring work, such as a defined batch test or translation of a current declaration. The third is response to a newly identified problem, which may include investigation, containment, worker support, product correction and remedy. Treating all three as routine overhead makes an unexpected but necessary response look like a request for discretionary administration.

¶ 02

The schedule should state the deliverable and approval route before naming a payer. For a test, identify the product components, question, method, sample relationship and recipient. For translation, identify the document, language, intended user and treatment of subsequent corrections. For a site assessment, identify scope, competence, access, unresolved findings and follow-up. For a system, identify the actual workflow and portability of the records. A purchase order for “compliance” without those details cannot show what completion means.

¶ 03

Worker engagement deserves its own resource line. Interviews, accessible grievance channels, interpreter support and remedy verification require time and suitable conditions. They should not be reduced to a signature collected during production. IFC Performance Standard 2 provides a finance-linked framework for fair treatment, safe and healthy working conditions, avoidance of child or forced labour and attention to primary-supply-chain risk. It is not an EU import regulation or a ready-made buyer-supplier cost clause.[S25]

¶ 04 · 1 source

S25

Administrative cost sharing differs from compensation for harm. A buyer can agree to fund a document portal while leaving a recruitment-debt case unresolved. A supplier can repay an affected worker while the parties still disagree about the portal fee. The contract should preserve these separate decisions. It should not state that payment of an audit fee, a sustainability charge or a capped evidence allowance automatically satisfies every corrective or remedial obligation.

¶ 05

Exhibit 52 shows how an incremental package can be made inspectable without inventing market prices. The figures are illustrative cost units, not CFA francs, euros, vendor quotations or GFT expenditure. The example assumes hourly rates solely to demonstrate multiplication and adds a separately assumed laboratory allowance. Actual negotiations need observed time, written scopes and current quotations.

The worked example supplies a negotiation order. Agree the necessary output, test whether existing evidence answers it, scope the remaining work, assign the payer and then address the commercial price. Starting with a fixed sustainability surcharge reverses that order. It can fund duplicated administration while leaving a decisive test or protective action unbudgeted.

¶ 07

12.52 min · 7 paragraphs · 1 exhibit

Assurance evidence must be assessed within its scope

Assurance language often hides a change of proposition. A supplier declaration states what its issuer asserts within a stated scope. A laboratory report addresses specified samples, methods and results. A site assessment examines selected sites, periods and findings. Product certification assesses a defined product against a scheme's criteria. Corporate reporting assurance addresses the information and engagement described in its own report. None becomes universal proof merely because it carries a signature or logo.

The EU Ecolabel provides a useful boundary. The Commission describes it as a voluntary scheme and states that independent experts check compliance with EU Ecolabel criteria. That verification concerns the scheme and its applicable criteria. It does not, by itself, establish physical safety, the absence of forced labour, every legal requirement for market access or the accuracy of every unrelated corporate statement.[S29]

¶ 02 · 1 source

S29

Corporate reporting has another boundary. Companies subject to the CSRD report according to ESRS. A supplier data extract can feed the reporting undertaking's work, but the extract does not become an ESRS statement or an independently assured supplier report through upload alone. The contract should identify who prepares the output, who reviews it and whether any external assurance is actually commissioned.[S03]

¶ 03 · 1 source

S03

Nor should third-party verification be sold as a due-diligence liability shield. The adopted CSDDD amendment expressly preserves possible liability under national law notwithstanding third-party verification or contractual clauses used to support implementation. The practical value of an assessment lies in the quality and relevance of its evidence, not in a claim that its existence ends the buyer's process.[S35]

¶ 04 · 1 source

S35

Exhibit 53 sets out these propositions without assigning a readiness score. The table distinguishes the output's proper use from conclusions it cannot support. Its last column is as important as its first: a reviewer should be able to say what remains unproved before accepting the evidence.

Exhibit 53RegistersourcedAssurance outputs prove different propositions
Output
EU Ecolabel verification
Proper proposition
Independent checking against applicable Ecolabel criteria
Does not by itself establish
General market access, safety or absence of forced labour

Read-outOutput: EU Ecolabel verification. Proper proposition: Independent checking against applicable Ecolabel criteria. Does not by itself establish: General market access, safety or absence of forced labour

Open the full register (4 rows)
EU Ecolabel verificationIndependent checking against applicable Ecolabel criteriaGeneral market access, safety or absence of forced labour
Corporate ESRS reportSustainability reporting by the undertaking within the reporting regimeAssurance over every supplier extract or product
Third-party due-diligence supportEvidence or assistance within the engagement and methodRemoval of possible liability under national law
Product-safety responseAction on an identified product concern by the relevant businessesA general sustainability or corporate compliance conclusion
Method and source

Sourced categorical synthesis of the opened institutional texts. The table does not rank assurance quality, certify any supplier or replace review of the actual report, criteria, engagement and legal role.

Unit: sourced scope distinctions. Status: sourced. Sources: S03, S29, S33, S35.

A reviewer should test independence, competence, sampling, exclusions, site coverage, issue date, expiry and unresolved findings. These are not decorative metadata. A technically sound report can still be irrelevant to the order if its sample does not match the batch or its site list omits the operation in question. Conversely, a missing badge does not prove that the underlying product fails a specific legal test.

¶ 01

The evidence schedule should record the review outcome as accepted for a defined purpose, accepted with limitations, requiring clarification or rejected for that purpose. “Approved” without the purpose is too weak. It invites a later team to reuse the report for a broader claim than its method permits. Where a report supports a public environmental statement, claims review remains another decision rather than an automatic extension of technical acceptance.

¶ 02

12.63 min · 8 paragraphs · 1 exhibit

Escalation should allow prevention, correction and remedy

Exhibit 548 paragraphs step it

Exhibit 54FlowillustrativeEscalation should protect people while resolving the product decision
Concern or evidence gapScope risk and protect people and productClarify evidence and investigateAgree corrective action and resourcesVerify product result and worker remedyRelease, continue, hold or escalateLegal review of suspension or exitMonitor recurrence and correction

Read-outConcern or evidence gap. Starting point. Leads to Scope risk and protect people and product.

Method and source

Illustrative GFT escalation design informed by the cited sources. It does not reproduce every statutory step, assign legal deadlines or promise a commercial outcome. The diagram simplifies concurrent operational work into one readable sequence. Suspension or termination requires separate legal and impact review.

Unit: illustrative decision sequence. Status: illustrative. Sources: S09, S10, S33, S35. Illustrative figures are teaching examples, not measured factory results.

12.6 · Introduction · paragraph 1 of 8

An escalation clause should begin with the decision required, not with a predetermined commercial punishment. An ambiguous record needs clarification. A product concern may need containment, technical assessment and a release hold. A worker concern may need protection before the facts are fully established. These actions can proceed in parallel, but they should not be treated as interchangeable outcomes or delayed until a routine contractual notice period expires.

The amended CSDDD text provides an important discipline for more serious disengagement decisions. Where the governing law entitles the company to suspend, its suspension provisions operate as a last resort in the stated circumstances and include enhanced prevention or corrective-action plans where there is a reasonable expectation of success. Before suspension, the company must assess whether its adverse impacts can reasonably be expected to be manifestly more severe than the impact concerned. If so, suspension is not required, but the company must be able to give duly justified reasons to the supervisory authority. Where suspension occurs, the text calls for steps to address its impacts, reasonable notice and continued review.[S35]

That legal framework should not be copied mechanically into every supply agreement. It does mean that “terminate immediately for any sustainability issue” is an inadequate operating design. The contract review should distinguish a temporary hold, suspension, termination and an authority order. It should identify who assesses worker consequences, who maintains communication and how a credible corrective path is reviewed. Continued engagement is not proof of effective prevention, but automatic exit can also leave harm unaddressed.

Product decisions need their own authority map. The Forced Labour Regulation introduces no routine audit or reporting obligation, while its investigation and decision process is distinct from a buyer's commercial precaution. A supplier or buyer shipment hold is therefore not the same event as an authority prohibition, withdrawal or disposal decision. The record should state who imposed the hold, under which contractual or legal route, for which products and on what evidence.[S10]

Where a business finds an unsafe product, EU guidance requires appropriate action and describes corrective measures including withdrawal and recall in the relevant circumstances. A contractual negotiation about evidence fees must not postpone that response. The escalation ladder should connect the commercial team to the qualified product decision-maker and preserve notices, affected batches and corrective evidence.[S33]

Exhibit 54 proposes a ladder that keeps worker protection visible throughout. It is not a statutory flowchart and assigns no universal deadlines. Its decision node separates routine monitoring from legal escalation. Clarification can resolve an evidence gap, while a verified remedy can inform the next commercial decision without rewriting the original incident.

Remedy needs evidence beyond administrative closure. The updated ILO and IOE handbook supports practical identification, prevention and mitigation of forced-labour risks; it does not supply a universal contractual remedy formula on the opened landing page. The parties should define the appropriate response to the actual harm, resources, affected-person confirmation where suitable and recurrence review. A buyer's cancelled order does not itself repay recruitment debt or restore safe work.[S09]

External dispute routes also need accurate descriptions. OECD National Contact Points provide a non-judicial grievance mechanism and may offer mediation where issues merit further examination. They do not guarantee admissibility, compensation or a court outcome, and they are not automatically available through an NCP in every supplier country. The contract should preserve applicable legal rights and routes rather than presenting one mediation channel as the exclusive answer.[S30]

12.72 min · 8 paragraphs · 1 exhibit

A negotiated evidence schedule can be reviewed before signature

The evidence schedule should be short enough to review and precise enough to operate. Each row should connect a requested field or output to its purpose, source record, format, update trigger, confidentiality treatment, cost owner and status. “Pending” should remain available for unresolved legal or technical questions. A schedule that marks every item agreed before the product and sales route are checked merely transfers uncertainty into the signature process.

Reusable reporting content should be identified separately from new investigation. The Commission presented the VSME recommendation as a way to make SME responses to large-company and financial-institution requests easier and encouraged requesters to base their questions on it as far as possible. This supports negotiation around a common core where the standard fits. It does not require a buyer to accept an incomplete answer to a product or risk question outside that reporting purpose.[S05]

¶ 02 · 1 source

S05

Exhibit 55 gives a fictional annex structure. Its payer entries are negotiation proposals, not statements of legal incidence. The rows distinguish reusable records from incremental work and mark issues that remain pending. They also prevent the cost discussion from erasing confidentiality and worker-safety conditions.

Exhibit 55RegisterillustrativeEvery information request should have a purpose and a cost owner
Evidence output
Batch composition file
Purpose, source and format
Label review; bill of materials; structured data
Update and access
On material change; buyer product reviewer
Proposed payer
Supplier routine record
Status
Reusable

Read-outEvidence output: Batch composition file. Purpose, source and format: Label review; bill of materials; structured data. Update and access: On material change; buyer product reviewer. Proposed payer: Supplier routine record. Status: Reusable

Open the full register (6 rows)
Batch composition fileLabel review; bill of materials; structured dataOn material change; buyer product reviewerSupplier routine recordReusable
Defined chemical testRestriction question; sampled components; PDF reportOn relevant recipe or supplier change; technical recipientsBuyer incremental feeScope pending
Common reporting coreReporting; controlled site records; standard templatePeriod close; reporting team onlySupplier within agreed administrationStandard check pending
Upstream risk extractRisk assessment; investigation records; redacted extractOn new material concern; restricted reviewersShared new investigationNecessity review
Worker-case outcomeRemedy verification; case record; status summaryOn reviewed case change; no raw identity packSeparate response budgetMethod pending
Portal adaptationBuyer submission; approved pack; buyer schemaOn schema change; named usersBuyer-specific administrationIncremental
Method and source

Illustrative GFT schedule for a fictional garment order. Payer and status entries are proposed negotiating positions, not statutory allocations or agreed GFT contract terms. Adapt purposes, evidence and access to the actual product, route, law and buyer requirement.

Unit: illustrative contract schedule. Status: illustrative. Sources: S05, S23, S35. Illustrative figures are teaching examples, not measured factory results.

Privacy fields require substantive review, not a general confidentiality label. Where GDPR applies, personal data collection must serve a specified purpose and remain limited to what is necessary. The schedule should therefore ask whether an aggregated answer, redacted record or controlled inspection can meet the need. Raw identity documents, grievance details and unrestricted onward access should not become default shipment attachments. Local law, lawful processing and any international-transfer assessment remain separate questions.[S23]

¶ 01 · 1 source

S23

The commercial schedule should distinguish included routine work, approved incremental work and exceptional response. It should identify the evidence of completion for each charge and prohibit silent expansion through a changed portal or template. If the buyer changes the schema after agreement, the change-control row should reopen only the affected mapping and effort. If the supplier changes the product or production route, its notification duty should reopen the relevant evidence even when no additional invoice is proposed.

¶ 02

Final legal review should cover governing law, enforcement, liability, indemnities, termination, mandatory local rules and the interaction between the schedule and the main agreement. This chapter has not verified a Member State civil-liability regime or the laws of a selected destination. Nor does it resolve whether any proposed clause is enforceable between particular parties. Those questions should remain express pending items rather than being settled by an operational template.

¶ 03

Before signature, each party should be able to answer five questions from the schedule itself. What must be delivered? Who performs the work? Who pays for incremental effort? Who decides when evidence is inadequate or a product must stop? How are people protected and remedy verified? If any answer depends only on a broad slogan in another clause, the negotiation is not complete.

¶ 04

GFT's Cameroon textile programme provides the design reference for shared ownership of production, quality, delivery, cost, people and sustainability records. It does not demonstrate a negotiated EU buyer contract or an implemented remedy mechanism. The practical recommendation is to connect the proposed evidence schedule to that operating record, so contractual duties draw on controlled factory evidence rather than creating a parallel account of production.

¶ 05

Check the record

The chapter keeps its sources within reach.

Every knot is a source this chapter cites; select one to read its record, or filter the register by grade. Publication dates and inherited-source limits stay explicit. Read the paper's full evidence summary.

13 sources · 44 citation marks on this pageMost cited: S35, 11 times

Grade AGrade BGrade CKnot size: citations on this page

All 13 records shown

c12-S02 · Grade A

European Commission

Corporate sustainability due diligence

This Directive establishes a corporate due diligence duty for the very large companies that fall within its scope.

n.d.. Register access date: 2026-10-30. Source provenance is supplied by the paper evidence register.

Open the recorded source ↗
Chapter source notes

S02 European Commission. n.d..

S33 European Union, Your Europe. 2026-08-19.

S35 European Parliament and Council of the European Union. 2026-02-24.

S23 European Commission. n.d..

S25 International Finance Corporation. 2012.

S03 European Commission, DG FISMA. 2026-07-03.

S04 European Commission, DG FISMA. 2026-07-03.

S05 European Commission, DG FISMA. 2025-07-30.

S07 OECD. 2026-02-26.

S29 European Commission, DG Environment. n.d..

S10 European Commission, DG GROW. n.d..

S09 International Labour Organization and International Organisation of Employers. 2025-11-26.

S30 OECD. n.d..

Keep the thread · chapter 12 of 14

Chapter 13 picks up the thread.

Move the shuttle along the rack to preview any chapter: its sections, exhibits and reading time. Draft web edition. This research is not investment, legal or tax advice; illustrative models are not measured factory results.

The paper's rack · 14 boltsBolt length: reading time

13Part IV: Operate the evidence system and fund its upkeep

The cost of evidence should be tested against the order it serves

A supplier needs a transparent cost model and a practical rehearsal rather than an assumed compliance premium.

  • 13.1The model must distinguish recurring work from setup
  • 13.2A comparable unit cost needs a consistent denominator
  • 13.3Request reuse should be measured rather than credited in advance
  • 13.4A shipment hold creates cash exposure rather than a forecast fine
Reading time
24 min
Exhibits
4
Sections
7
Continue to chapter 13
← Previous: chapter 11, Compliance data must be useful without exposing the workerContinue the threadChapter 13 · The cost of evidence should be tested against the order it serves

Find a thread.

Type to search.